Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Petersenn

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Journal of Clinical Pharmacology|June 16, 2011
Pasireotide (SOM230), a novel multireceptor-targeted somatostatin analogue, is well tolerated when administered as a continuous 7-day subcutaneous infusion in healthy male volunteersStephan Petersenn, Nicole Unger, Ke Hu, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 23, 2026
[Need for Improvement in Healthcare Provision for Rare Endocrinological Diseases in Germany Using the Example Endogenous Cushing's Syndrome]Linus Haberbosch, Martin Fassnacht, Martin Reincke, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumorsThorsten D Poeppel, Ina Binse, Stephan Petersenn, et al.
European Journal of Endocrinology|March 23, 2023
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the questionJacqueline Trouillas, Pia Burman, Marco Losa, et al.
European Journal of Endocrinology|February 25, 2006
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massNicole Unger, Christian Pitt, Ingo Lopez Schmidt, et al.
European Journal of Endocrinology|January 21, 2015
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registryStephan Petersenn, Paul-Ajoy Richter, Thomas Broemel, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?Stephan Petersenn, Mirjam Christ-Crain, Michael Droste, et al.
Endocrine|May 23, 2016
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide studyJames W Findling, Maria Fleseriu, John Newell-Price, et al.
Clinical Endocrinology|November 23, 2007
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursNicole Unger, Inna Serdiuk, Sien-Yi Sheu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 22, 2021
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaAnja Rinke, Christoph Maintz, Lothar Müller, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacology|June 16, 2011
Pasireotide (SOM230), a novel multireceptor-targeted somatostatin analogue, is well tolerated when administered as a continuous 7-day subcutaneous infusion in healthy male volunteersStephan Petersenn, Nicole Unger, Ke Hu, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 23, 2026
[Need for Improvement in Healthcare Provision for Rare Endocrinological Diseases in Germany Using the Example Endogenous Cushing's Syndrome]Linus Haberbosch, Martin Fassnacht, Martin Reincke, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumorsThorsten D Poeppel, Ina Binse, Stephan Petersenn, et al.
European Journal of Endocrinology|March 23, 2023
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the questionJacqueline Trouillas, Pia Burman, Marco Losa, et al.
European Journal of Endocrinology|February 25, 2006
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massNicole Unger, Christian Pitt, Ingo Lopez Schmidt, et al.
European Journal of Endocrinology|January 21, 2015
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registryStephan Petersenn, Paul-Ajoy Richter, Thomas Broemel, et al.
Geburtshilfe Und Frauenheilkunde|April 20, 2019
Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?Stephan Petersenn, Mirjam Christ-Crain, Michael Droste, et al.
Endocrine|May 23, 2016
Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide studyJames W Findling, Maria Fleseriu, John Newell-Price, et al.
Clinical Endocrinology|November 23, 2007
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursNicole Unger, Inna Serdiuk, Sien-Yi Sheu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 22, 2021
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaAnja Rinke, Christoph Maintz, Lothar Müller, et al.
Pageof 13